To the Top
Data visualization
Release Calendar 2026
Health statistics glossary
OECD database: health
Eurostat database
WHO Health for All databases
The 3 steps are Choose table, Choose variable and Show result. You are currently at Choose variable

VSR17: Detected cancer cases in cervical cancer screening programme

Choose variables

11/13/2025
number
Estonian Cancer Screening Register, National Institute for Health Development
VSR17
Detailed information
vsrinfo_en
Now you have come to the page, Choose variable. This page give you the oportunity to select which variables and values you want to display in your result of the table. A variable is a property of a statistical unit. The page is divided into several boxes, one for each variable, where you can select values by click to highlight one or more values. It always starts with the statistics variable which is the main value counted in the table.
Mark your selections and choose between table on screen and file format. Marking tips
Field for searching for a specific value in the list box. This is examples of values you can search for.Target population , Excluded from screening (cancer diagnosed before the screening programme) , Invited to screening ,

Selected 0 of total 23

Field for searching for a specific value in the list box. This is examples of values you can search for.2015 , 2016 , 2017 ,

Selected 0 of total 9

Number of selected data cells are:
(maximum number allowed is 800,000)

Presentation on screen is limited to 6,000 rows and 80 columns

Number of selected cells exceeds the maximum allowed 800,000

Obs:

Definitions and methodology Target population - people residing in Estonia of eligible age and sex (source: the population register) according to the screening programme policy.
Excluded from screening (cancer diagnosed before screening) - screening population individual has been diagnosed with cervical cancer or other gynaecological cancer (ICD-10 codes C51, C52, C53, C54, C55 and D06) in the five years before the screening year. Individuals are not invited to screening.
Invited to screening - people in the target population who have not been diagnosed with cervical cancer in the past five years (source: Estonian Cancer Registry and Health Information System, ICD-10 codes C51, C52, C53, C54, C55 and D06).
Did not participate in the screening programme - the registry has not received any HPV screening document.
Participated in the screening programme - the registry has received an HPV screening document during the specific screening year or January of the following year.
Participated in the screening programme, primary study result negative - the registry has received an HPV screening document with a negative result.
Participated in the screening programme, primary study result unknown - the registry has received an HPV screening document without a result.
Participated in the screening programme, primary study result positive - the registry has received an HPV screening document and the individual has been referred for an additional study (cytology or Papanicolaou test, colposcopy, biopsy).
Did not participate in the additional study - the registry has received an HPV screening document and the individual has been referred for an additional study but the additional study document has not been received.
Participated in the additional study - the registry has received an HPV screening document, individual has been referred for an additional study and the registry has received an additional study document.
Additional study result negative - the registry has received an HPV screening document and an additional study document (cytology or Papanicolaou test, colposcopy, biopsy) with a negative result.
Additional study result unknown - the registry has received an HPV screening document and an additional study document (cytology or Papanicolaou test, colposcopy, biopsy) without a result.
Detected precancerous conditions - the registry has received an HPV screening document and an additional study document (cytology or Papanicolaou test, colposcopy, biopsy) and the result of the additional study document is a precancerous condition.
Detected cervical cancer (C53 or D06) - the registry has received an HPV screening document and an additional study document (cytology or Papanicolaou test, colposcopy, biopsy), cervical cancer (ICD-10 codes C53 or D06) has been diagnosed as the result of the biopsy or according to Estonian Cancer Registry.
Interval cancer - cervical cancer (ICD-10 codes C53 and D06) diagnosed within 60 months after participating in the screening programme in individuals whose screening result was 'primary study result negative', 'primary study result unknown' or 'additional study result negative'.
Cancer detected among non-participants - target population's individuals who did not participate in the screening programme but were diagnosed with cervical cancer (ICD-10 codes C53 or D06) during the specific screening year or the following four years. In the 2015-2020 data, 'additional study result unknown' includes all those who did not participate in the additional survey. 23.04.2025 updated data for 2015-2021.
23.04.2025 updated table structure.
The dataset gives a statistical overview and summary results of cervical cancer screening programmes, the size of the screening target population, the number of individuals invited to the screening, the number of individuals who did not participate in the screening and those who did participate, and a summary of the results of the screening for those who participated (test result negative, unknown, positive, incl. participation in additional testing and its results (negative, unknown, positive, i.e. precancerous changes found or cervical cancer detected during screening by cancer stage)). The number of interval cancer cases in individuals in the screening target population and the number of cancer cases among individuals who did not participate in screening are also provided. The purpose of the data is to support the organisation and monitoring of screening programmes, to assess target group coverage and participation, to track screening outcomes, and to use the data for evaluating the quality and effectiveness of screening and for epidemiological analyses. Data source: Estonian Cancer Screening Register, National Institute for Health Development